Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Willson
S Lawrence

Showing results (1351-1360 of 1,504) with videos related to

Pageof 151
Sort By:
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Science Translational Medicine|November 22, 2013
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRVeerle Rottiers, Susanna Obad, Andreas Petri, et al.
Neoplasia (New York, N.Y.)|January 9, 2023
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastomaWajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, et al.
Cell Reports. Medicine|October 5, 2023
End binding-3 inhibitor activates regenerative program in age-related macular degenerationQuinn Lee, Wan Ching Chan, Xinyan Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2024
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung CancerDonna M Edwards, Caitlin A Schonewolf, John D Rice, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
NPJ Precision Oncology|July 26, 2019
Blood-based monitoring identifies acquired and targetable driver <i>HER2</i> mutations in endocrine-resistant metastatic breast cancerArielle J Medford, Taronish D Dubash, Dejan Juric, et al.
Nature Communications|March 16, 2025
APC/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degronsAleksandra Skrajna, Tatyana Bodrug, Raquel C Martinez-Chacin, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
Pageof 151

Showing results (1351-1360 of 1,504) with videos related to

Sort By:
Pageof 151
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Science Translational Medicine|November 22, 2013
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRVeerle Rottiers, Susanna Obad, Andreas Petri, et al.
Neoplasia (New York, N.Y.)|January 9, 2023
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastomaWajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, et al.
Cell Reports. Medicine|October 5, 2023
End binding-3 inhibitor activates regenerative program in age-related macular degenerationQuinn Lee, Wan Ching Chan, Xinyan Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2024
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung CancerDonna M Edwards, Caitlin A Schonewolf, John D Rice, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
NPJ Precision Oncology|July 26, 2019
Blood-based monitoring identifies acquired and targetable driver <i>HER2</i> mutations in endocrine-resistant metastatic breast cancerArielle J Medford, Taronish D Dubash, Dejan Juric, et al.
Nature Communications|March 16, 2025
APC/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degronsAleksandra Skrajna, Tatyana Bodrug, Raquel C Martinez-Chacin, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
Pageof 151